WA
AMGN icon

Wambolt & Associates’s Amgen AMGN Stock Holding History

Wambolt & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$236K Buy
+811
New +$230K 0.08% 164

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Wambolt & Associates's AMGN Position: Q2 2025 in Review

Wambolt & Associates opened a new position in Amgen (AMGN) in Q2 2025: 811 shares worth $236K. The stake represents 0.08% of the portfolio and ranks #164 among its holdings.

2,851 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • Wambolt & Associates held 811 shares of Amgen worth $236K as of Q2 2025.
  • Amgen was a new Wambolt & Associates position in Q2 2025.
  • Amgen made up 0.08% of Wambolt & Associates's portfolio in Q2 2025, its #164 holding.
  • 2,851 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Wambolt & Associates's 13F filing for Q2 2025, filed 13 Aug 2025.